Recently, Secretary-General Cencan Xia, Director Duan Zhao, and Director Genxing Shen from China Association for Promotion of Health Science and Technology, as well as Secretary-General Guoying Chen from the China Health Promotion Foundation visited RainMed Medical's Beijing office. During the visit, they expressed their high recognition and appreciation for RainMed’s persistent spirit of innovation and entrepreneurship, as well as its high-quality output. Professor Yunlong Huo, founding shareholder of RainMed Medical and professor of Shanghai Jiao Tong University School of Life Science and Biotechnology, accompanied the delegation along with Liang Wan, Director of RainMed’s Government Affairs Department.

On behalf of the company, Professor Huo Yunlong extended a warm welcome to the leaders and systematically introduced RainMed's development history, R&D progress, product layout and innovation achievements. He stated that achieving domestic innovation was his original intention when returning to China for entrepreneurship, and it is also the shared commitment of RainMed Medical. RainMed Medical has always adhered to the purpose of "Targeted Medical Services for People's Health", persisted in independent innovation, increased R&D investment, and launched a series of innovative diagnosis and treatment products for vascular diseases. In the future, it will also continue to focus on international cutting-edge technologies, overcome the challenges of complex disease diagnosis and treatment, and contribute Chinese wisdom to the development of precision medicine for vascular diseases.

Secretary-General Cencan Xia expressed his appreciation for Professor Huo Yunlong's  patriotism and dedication to science and technology. He praised the company's complete patent layout and outstanding clinical value, and congratulated the commercialization of the caIMR system. He pointed out that the caIMR system is one of the world's best microcirculation diagnostic technologies, leading the field of vascular disease functional assessment. As a leading enterprise in the industry, RainMed Medical must shoulder heavy responsibilities, deeply implement the Party Central Committee's instructions, persist in independent R&D, and achieve better results in the field of precision medicine.

Secretary-General Guoying Chen inquired in-depth about the working principles, design and manufacturing processes of RainMed Medical's series of functional diagnostic products, as well as their domestic and international sales. He expressed his recognition for RainMed's perseverance in independent innovation and its competitive strength. The caFFR system and caIMR system of RainMed Medical, as leading innovative functional diagnostic methods in China, greatly optimize intraoperative procedures, improve diagnostic efficiency, and bring new opportunities for the clinical popularization of functional assessment. It is hoped that RainMed Medical will shoulder the mission and responsibility of a national high-tech enterprise, continue to overcome key technical challenges in the field of vascular diseases, and to promote China's healthcare development to new heights.

Enterprises are the embodiment of technological innovation. As a national high-tech enterprise, RainMed Medical has always prioritized clinical needs, and has developed and launched a series of revolutionary precision diagnosis and treatment products for vascular diseases, receiving attention and care from all sectors of society. In the future, RainMed Medical will continue to deepen scientific research and innovation, contribute to precision medicine, and use original Chinese technology to safeguard global patients.